Somedeb Ball
@drsomedebLeukemia Doc @VUMCDiscoveries @VUMC_cancer via Chief Fellow @MoffittNews, IM @TTUHSC, Alum @ASCO @AACR,🇮🇳 in 🇺🇸, Proud Dad of 3 👶, 🎯Rx #leusm, 🔭 my own
Similar User
@Ramikomrokji
@DrFredLocke
@AkritiGJain
@MKD_BMT
@drsangeetmd
@beatalleukemia
@KuykendallMd
@jaltmanmd
@LeukDocJZ
@NicholasShortMD
@RaajitRampal
@ZhuoerXie
@bose_prithviraj
@yumengzhang2009
@GBorthakur
It was an honor to co-lead this global effort on behalf of #MDSsm community! Learned a lot in process. Forever thankful to @Ramikomrokji for the opportunity. Hope our framework paves way for future WHO/ICC harmonization @Dr_AmerZeidan @LucaLanino @ic_MDS @VUMCHemOnc @VUMC_Cancer
Data-driven, harmonised classification system for MDS sciencedirect.com/science/articl… It took a global effort for this project using largest MDS cohort to date from Moffitt and Genomed datasets. Thx to all my dear coauthors @MoffittNews @Dr_AmerZeidan @drsomedeb @genomed4all @ic_MDS
Very interesting study in @BloodJournal looking at pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)! sciencedirect.com/science/articl…
Each patient w #MDSsm needs an individualized assessment, prognostication, and management. Let's call for a holistic approach to improve quality of life and outcomes! #MDSAwarenessDay @AshKishtagari @ZhuoerXie @MariaAmaya_27 @aditishasMD @LeukDocJZ @Ramikomrokji @Dr_AmerZeidan
On MDS Awareness Day, spread the word: most cases of MDS, or Myelodysplastic Syndromes, have an unknown cause. Find out more about possible causes here: aamds.org/mds/causes
Exciting day at @US_FDA brainstorming prognostic factors and clinical trial endpoints in AL Amyloidosis!
Dr. @rajshekharucms presenting the #AmyloidosisForum Prognostic Factors working group's plans to develop prognostic factors for clinical trial endpoints with quantitative assessments and validation that reflects current standards of care in #amyloidosis
CAR-T cells for AML: will we be able to overcome the obstacles? Please join this exciting @TheIACH webinar tackling one of the most difficult topics in immunotherapy today. Registration: us06web.zoom.us/webinar/regist… @KNOW_AML @Dr_AmerZeidan @doctorpemm
Many congrats!! @CathyEngMD
Exciting news! @CathyEngMD has been appointed Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer Center. She will enhance clinical research through strategic partnerships with pharma and biotech companies. Congratulations, Dr. Eng!
Absolutely phenomenal @VUMCHemOnc @VUMCDiscoveries grand rounds this morning by none other than @AACRPres! It's fascinating to hear about the inspiring journey from one of the best in #clinicaltrial #disparity #drugdevelopment in Oncology!! @jordanberlin5 @VUMC_Cancer
Had a fantastic visit to @ClevelandClinic Translational Hematology and Oncology Research program to give a talk on Clonal Hematopoiesis. Grateful for the insightful discussions and collaboration! Thank you Drs. Maciejewski & @Saunthararajah for the invite.
👉👉👉Special shout out to @btfoundation team for hosting such a wonderful meeting! 🙏 @binayshah @NitinJainMD @BldCancerDoc @SoniSmithMD @myelomaMD for organizing! See you next year! 🙌 @myeloidmalig @sanamloghavi @doctorpemm | #MPNSM #leusm #bmtsm
Thanks to @btfoundation #HemeSummit24 for the chance to speak about MPN-AP/BP! -no standard approach to treatment & current strategies have limited utility -clinical trials inclusive of MPN-AP/BP are desperately needed! -we are looking to prospectively study IDHi & LSD1i
Superb talk by @Anand_88_Patel addressing the critical unmet need in treating accelerated and blast phase MPN at @btfoundation the 2024 Summit on Hematological Cancers in Nashville. What new strategies can help tackle this high-risk phase of disease? #MPNsm
Dr. @doctorpemm explores the potential of novel JAK inhibitors in myelofibrosis at the 2024 Summit on Hematological Cancers in Nashville: Are we on the brink of redefining treatment strategies and improving patient outcomes? #MPNSm
➡️ Addressing unanswered questions in CML by @FadiHaddad_MD! - Increasing rates of successful TFR - CML treatment equity and CML treatment value Great talk. @btfoundation #CML
Wonderful hemonc meeting by @btfoundation chaired by @NitinJainMD @BldCancerDoc @SoniSmithMD @myelomaMD Nice talks by @GBorthakur @drsomedeb @doctorpemm @CarrawayHetty @sanamloghavi and others!
Wonderful to meet colleagues and friends at the @btfoundation meeting in Nashville @FadiHaddad_MD @jayastuMD @nihardesai7 @niranjankhaire @doctorpemm
Don't miss @drsomedeb from @VUMChealth as he shares treatment options for relapsed AML Triplets at #HemeSummit24 #MedTwitter #MedX #MedEd
Thank you @sanamloghavi ! There are some benefits of following great hematopathologists on this platform! 😊
Well done Dr. @drsomedeb … any talk that begins with a 360° #hemepath approach on the title slide is 👌🏼in my book …. First step: gotta get the diagnosis right ✅ #hemepath
👉👉👉Awesome meeting and talks! @btfoundation @binayshah | @HimaglobinA @HannahGoulart @sparikhmd @mkonople @GBorthakur @NitinJainMD @BldCancerDoc || #leusm #MPNSM #mmsm
Dr. @mkonople tackles the critical question of Venetoclax in AML/ALL at the 2024 Summit on Hematological Cancers in Nashville: Which patient subsets should receive it, and why? A deep dive into optimizing targeted therapy in leukemia treatment. #AMLsm #ALL #Venetoclax
Dr. @CarrawayHetty addresses a critical unmet need at the 2024 Summit on Hematological Cancers in Nashville: how do we manage MDS after HMA failure? Exploring new strategies and therapeutic options for high-risk patients. #MDSsm
@drsomedeb dives into the evolving landscape of treatment options for R/R AML: where do we stand, and what’s next? Navigating novel combinations and overcoming resistance at the @btfoundation 2024 Summit on Hematological Cancers in #Nashville #AMLsm
Exciting insights from @GBorthakur at the 2024 Summit on Hematological Cancers @btfoundation in Nashville navigating the complexities of frontline therapy in AML in 2024. How do we balance novel targeted therapies with traditional cytotoxic regimens for optimal patient…
United States Trends
- 1. $PUMP 1.797 posts
- 2. Joe and Mika 1.418 posts
- 3. Good Monday 38,7 B posts
- 4. #MorningJoe N/A
- 5. #MondayMotivation 13,2 B posts
- 6. Mika and Joe 1.548 posts
- 7. #MondayVibes 2.182 posts
- 8. Victory Monday N/A
- 9. #18Nov 1.925 posts
- 10. Bengals N/A
- 11. #MondayMood 1.596 posts
- 12. Chargers 72,5 B posts
- 13. WWIII 202 B posts
- 14. 60 Minutes 39,3 B posts
- 15. Margaret Thatcher 5.747 posts
- 16. Rusia 2.423 posts
- 17. Myron 13,3 B posts
- 18. Herbert 36,6 B posts
- 19. Brendan Carr 15,9 B posts
- 20. Burrow 40,8 B posts
Who to follow
-
Rami komrokji
@Ramikomrokji -
Frederick L. Locke
@DrFredLocke -
Akriti Jain
@AkritiGJain -
Mohamed Kharfan-Dabaja, MD, MBA
@MKD_BMT -
Sangeetha Venugopal MD,MS
@drsangeetmd -
Dr. Uma Borate: Associate Professor
@beatalleukemia -
Andrew Kuykendall MD
@KuykendallMd -
Jessica Altman, MD
@jaltmanmd -
Joshua Zeidner MD
@LeukDocJZ -
Nicholas Short MD
@NicholasShortMD -
Raajit Rampal, M.D.Ph.D.
@RaajitRampal -
Zhuoer (Zoey) Xie, MD, MSCR
@ZhuoerXie -
Prithviraj Bose
@bose_prithviraj -
Yumeng (Julia) Zhang
@yumengzhang2009 -
Gautam Borthakur
@GBorthakur
Something went wrong.
Something went wrong.